EX-32 6 pmvp-ex32_1.htm EX-32.1

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of PMV Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David H. Mack, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

-1-

FILENAME \* MERGEFORMAT Normal.dotm

Date: March 1, 2023

| PMV PHARMACEUTICALS, INC.
| By: | /s/ David H. Mack
| Name: | David H. Mack, Ph.D.
| Title: | Chief Executive Officer (Principal Executive Officer)

-1-

FILENAME \* MERGEFORMAT Normal.dotm